We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.

Suitcase

Joint Statement HPS (TRAVAX) and NaTHNaC: Designated State Parties for Yellow Fever Provision in the UK

17 June 2015

Re: Revised recommendations for yellow fever vaccination and Certificate Requirements 2015

The World Health Organization (WHO) has published the updated recommendations for yellow fever vaccination and certificate requirements, submitted by member states, for 2015. Some countries have included a statement on validity of the International Certificate of Vaccination or Prophylaxis (ICVP) (i.e. 10 years or lifelong). This follows the WHO declaration in May 2013 that protection from yellow fever vaccination is considered to be lifelong for immunocompetent individuals. It should be noted that not all countries state their position with regards ICVP validity.

For more detailed information, see the news item / clinical update and individual country reports on TRAVAX and NaTHNaC (currently being updated). Further information will be posted when available.